RxDoctor Payments Data

Tina Baykaner, MD

Clinical Cardiac Electrophysiology · Stanford, CANPI 1760786818

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (43.0%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Medtronic at 27.3% of the total. 2025 is the largest year on record at $49,926, more than ten times the $2,794 reported in 2019.

$167,744in general payments, 2019–2025

Across 356 payments — averaging $471.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$46K
  • Biotronik Inc.$45K
  • Boston Scientific$26K
  • Volta Medical Inc$17K
  • Abbott$14K
  • Medical Device Business Services, Inc.$13K
  • plus $8K from 5 others
$305,753in research payments, 2019–2025

Across 21 payments — averaging $14,560 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Janssen Research & Development, LLC$306K

What the payments were for

  • Consulting fees$18,70011%
  • Speaking & faculty fees$61,07636%
  • Travel & lodging$72,07043%
  • Food & beverage$15,8989%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$167,744 in reported general payments places this provider in the 85th percentile of 290 clinical cardiac electrophysiology providers in California.

See all clinical cardiac electrophysiology providers in California

Medicare billing

Part B allowed, 2024
$165,988
Medicare patients
753
Services billed
1,526

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban108$137,323
XareltoRivaroxaban20$26,836
Flecainide Acetate76$3,177
Mexiletine Hcl14$1,851
Metoprolol Succinate89$1,246
Amiodarone Hcl33$714
Sucralfate26$417
Carvedilol16$192
Pantoprazole Sodium22$174
Metoprolol Tartrate12$86

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Stanford

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →